Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

AVTXAVTX
8 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in AVALO THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 1.1M shares of AVTX (AVALO THERAPEUTICS INC), worth $20.4M as of 2026-Q2. The position was increased (+550.5% shares). AVTX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$20.4M

Current Shares

1.1M

Total Value Change

+$20.3M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+550.5%
$20.4M0.0%$18.48
46
2026-Q1
Increased
169,889
+2.3%
$2.5M0.0%$18.85
27
2025-Q4
Increased
166,152
+59.5%
$3M0.0%$17.81
38
2025-Q3
Decreased
104,189
-5.7%
$1.3M0.0%$13.02
0
2025-Q2
Increased
110,460
+2.5%
$551,6130.0%$4.78
17
2025-Q1
Increased
107,812
+2.8%
$864,3890.0%$8.46
26
2024-Q4
Increased
104,853
+937.0%
$779,0570.0%$7.80
40
2024-Q3
New
10,111
-
$95,6490.0%$9.40
33

Other major holders of AVTX: FMR LLC, BlackRock, Inc., STATE STREET CORP, FARALLON CAPITAL MANAGEMENT, L.L.C., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used